| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Presentation > Presentation: Five Mistakes That Lead To Over Selling And Losing the Sale |
|
Just Other Articles - Presentation: Five Mistakes That Lead To Over Selling And Losing the Sale
Over selling is probably the most common mistake that a person makes when giving a presentation. Over selling is basically talking onese According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product lf out of a sale. We have all done it and will probably do it again. There is a fine line between giving too little information in a pre ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in entation, to giving too much. It takes preparation, practice, and discipline to fine tune the skill of giving a powerful presentation. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. isted below are five key mistakes presenters often make: 1. Not being prepared. Plan in advance. Know your information inside and out here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe . Bullet point your ideas and outline them on a piece of paper. Repeatedly practice your presentation out loud until it becomes natural d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro o you. If possible do research on the person or person's you are giving the presentation to. Insight to your client can help you gear i ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc formation to them. 2. Not listening. Sometimes we can become so anxious to give the presentation, that we are not listening or asking i easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi mportant key questions. If we do not understand their needs, we will not be able to show them the value of our service or product. We l nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ve in a fast pace society and no one has time to sit and listen endlessly to someone talk. You do not want this to go to the other extrem and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ . Keep control of the presentation. 3. Talking about themselves. It is appropriate to bring up a personal testimony or establish credi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ility. However, getting into lengthy details about ones personal life will only frustrate and alienate the client or customer. The pres ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a entation should be about what benefits you can give them. 4. Not being considerate of the other person's time. If you tell your client dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod that it will only take half and hour, then only take half an hour. They are taking time out of their busy schedule to let you present to cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin them. They are expecting you to honor your commitment by valuing their time. It is important to understand that it is hard to hold some tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen one's attention if the presentation becomes too lengthy. Another aspect of giving a lengthy presentation is that you will look desperate t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel for the sale and not confidant in your product or service. 5. Giving too much detailed information about your product or service. Peop ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e can only absorb
so much information at one time. Too much information will confuse them and lose their interest. It is better to l y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products eave them wanting more, than to give them too much and leave them frustrated. Having the opportunity to give a presentation to a potenti . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de l client is invaluable. Following through with a well communicated presentation can have significant results. It is an opportunity you elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip o not want to waste. The main purpose is to highlight, show value and display credibility. Beyond that you run the risk of over selling tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Problem Solving / Corrective Action Franchising Agreements with LLC or Limited Partnership Franchisee and Transfers Program Management and Strategy Alignment
|